Tianjin Lisheng PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Tianjin Lisheng PharmaceuticalLtd has a total shareholder equity of CN¥5.0B and total debt of CN¥80.1M, which brings its debt-to-equity ratio to 1.6%. Its total assets and total liabilities are CN¥6.0B and CN¥1.0B respectively. Tianjin Lisheng PharmaceuticalLtd's EBIT is CN¥80.6M making its interest coverage ratio -0.6. It has cash and short-term investments of CN¥2.3B.
Key information
1.6%
Debt to equity ratio
CN¥80.12m
Debt
| Interest coverage ratio | -0.6x |
| Cash | CN¥2.27b |
| Equity | CN¥5.00b |
| Total liabilities | CN¥1.01b |
| Total assets | CN¥6.02b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002393's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥746.5M).
Long Term Liabilities: 002393's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥267.4M).
Debt to Equity History and Analysis
Debt Level: 002393 has more cash than its total debt.
Reducing Debt: 002393's debt to equity ratio has increased from 0.6% to 1.6% over the past 5 years.
Debt Coverage: 002393's debt is well covered by operating cash flow (261.9%).
Interest Coverage: 002393 earns more interest than it pays, so coverage of interest payments is not a concern.